Why the study?
Does pilocarpine prevent arrhythmias in aconitine-induced rat and ouabain-induced guinea pig models?
Does pilocarpine prevent arrhythmias in aconitine-induced rat and ouabain-induced guinea pig models?
Pilocarpine exhibits antiarrhythmic properties in animal models of arrhythmia, potentially mediated by M3-muscarinic receptor activation and attenuation of calcium overload.
Should not change practice; hypothesis-generating for M3-mediated antiarrhythmics, warranting human trials.
This study was designed to evaluate the effects of pilocarpine and explore the underlying ionic mechanism, using both aconitine-induced rat and ouabain-induced guinea pig arrhythmia models. Confocal microscopy was used to measure intracellular free-calcium concentrations ([Ca(2+)](i)) in isolated myocytes. The current data showed that pilocarpine significantly delayed onset of arrhythmias, decreased the time course of ventricular tachycardia and fibrillation, reduced arrhythmia score, and increased the survival time of arrhythmic rats and guinea pigs. [Ca(2+)](i) overload induced by aconitine or ouabain was reduced in isolated myocytes pretreated with pilocarpine. Moreover, M(3)-muscarinic acetylcholine receptor (mAChR) antagonist 4-DAMP (4-diphenylacetoxy-N-methylpiperidine-methiodide) partially abolished the beneficial effects of pilocarpine. These data suggest that pilocarpine produced antiarrhythmic actions on arrhythmic rat and guinea pig models induced by aconitine or ouabain via stimulating the cardiac M(3)-mAChR. The mechanism may be related to the improvement of Ca(2+) handling.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: